TGFB1 and neoplasm: Interest was however, rekindled in utilizing this approach for therapeutic benefit, when it was demonstrated that TGFβ signaling, in certain subsets of cancer patients like BLBC, contribute to immunosuppression in the tumor microenvironment and immune evasion by the tumor.